A comparative study to evaluate the safety & efficacy of Etoricoxib and Piroxicam in pharmacotherapy of Osteoarthritis in tertiary care hospital Kanpurâ??â??

PRINC BGHEA0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Patients with symptomatic osteoarthritis of age 35 to 65 years who fulfill the western Ontario and McMaster universities osteoarthritis index (WOMAC)
•2. Criterion for the diagnosis of osteoarthritis will be enrolled.
•3. Patients having symptomatic Osteoarthritis either as a new case or as an old case following discontinuation of treatment with NSAIDS or other analgesic medications with a washout period of one week
•4. All these patients will be examined as per the baseline criteria will be included in the study if they fit this criterion.

•1. Smokers/ alcoholics
•2. Pregnant & lactating women.
•3. Patients on steroid therapy, history of chronic infections like TB, leprosy, recent trauma, surgery, mental retardation, minor.
•4. Patients with liver diseases, kidney diseases, and cardiac problems.

发起方

PRINC BGHEA